Sinopharm Tech Holdings Limited reported earnings results for the third quarter and nine months ended March 31, 2023. For the third quarter, the company reported sales was HKD 4.73 million compared to HKD 26.2 million a year ago. Net loss was HKD 6.32 million compared to HKD 9.91 million a year ago. Basic loss per share from continuing operations was HKD 0.035 compared to HKD 0.055 a year ago.
For the nine months, sales was HKD 19.75 million compared to HKD 37.93 million a year ago. Net income was HKD 9.09 million compared to net loss of HKD 23.41 million a year ago. Basic earnings per share from continuing operations was HKD 0.05 compared to basic loss per share from continuing operations of HKD 0.13 a year ago.